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ABSTRACT
Objective: To evaluate the effectiveness of
biopsychosocial Self-Management Support (SMS)
delivered by practice nurses in routine diabetes care.
Design: A pragmatic cluster-randomised controlled
trial within a hybrid effectiveness-implementation study
design. Practice nurses were cluster-randomised.
Setting: A regional care group in the Netherlands
consisting of 77 family practices. The study involved
practice nurses (n=40) providing care to approximately
4000 patients with diabetes.
Participants: Patients with type 2 diabetes (n=264)
selected by a self-administered questionnaire aimed at
measuring emotional distress and diabetes-related
reduced daily functioning.
Intervention: Practice nurses in the intervention arm
(n=19) were trained to integrate SMS into their routine
consultations. SMS included detection of patients with
emotional distress and reduced daily functioning, and
supporting them when needed through problem
solving and reattribution techniques. Practice nurses in
the control arm (n=21) provided usual care.
Main outcome measures: The primary outcome
measure was a dichotomised score on a Visual
Analogue Scale that measured the perceived effect of
diabetes on daily functioning. Secondary measures
included patients’ diabetes-related distress, quality of
life, autonomy and participation, self-efficacy, self-
management and glycaemic control. Outcomes were
measured at baseline and at 4-month and 12-month
follow-ups.
Results: Only 16 of the 117 patients in the
intervention arm (14%) who were found eligible by the
posted research-driven screening questionnaire were
detected by their practice nurses. Extra consultations
for the self-management support were delivered to only
11 study participants. In the control arm, 147 patients
received usual care. Multilevel analyses showed no
significant differences in outcomes between the
intervention and control arms.
Conclusions: SMS in its present form was not
effective. The research-driven screening to select trial
participants appeared to be inconsistent with nurse-led
detection in routine practice. Adequate follow-up
moments need to be built in to overcome barriers
resulting from tension between the implementation and
effectiveness parts of hybrid studies.
Trial registration number: Current Controlled Trials
NTR2764.
INTRODUCTION
Patients with chronic diseases such as type 2
diabetes mellitus have to deal with challen-
ging day-to-day management tasks regarding
the medical, emotional and social conse-
quences of their chronic condition.1 2
Research has shown a reciprocal relationship
between the emotional health status of
people with diabetes and their medical self-
management: emotional distress may inter-
fere with control over the disease, whereas
poor control over the disease can lead to
emotional distress.3–6 Studies highlight the
need to support the medical as well as the
emotional and role management tasks in
newly diagnosed patients and patients who
face the longer-term consequences of their
chronic condition.7–9
Strengths and limitations of this study
▪ A thorough cluster-randomised trial to evaluate
the effectiveness of an evidence-based interven-
tion integrated into routine primary care.
▪ Limited interference of the researcher in the
routine care setting.
▪ Low exposure of study participants to the com-
plete intervention.
▪ Absence of a pilot of the detection method prior
to implementation.
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In European countries, most patients with diabetes
receive follow-up care in the primary care setting by
nurses.10 Practice nurses (PNs) in the Netherlands work
according to guidelines that focus on medical and
behavioural management.11 12 Furthermore, the ﬁnan-
cial reimbursement of care and patients’ health out-
comes are determined by biomedical targets.13
Consequently, the psychosocial aspects of diabetes
care are not systematically incorporated in clinical
practice.10 13–15
In collaboration with a regional care group of general
practitioners (GPs) in the Netherlands and a health
insurer, the SMS (‘Self-Management Support’) imple-
mentation project was initiated to realise a shift from
biomedically oriented care towards a biopsychosocial
approach in diabetes care.16 The starting point was a
nurse-led minimal psychological intervention. A previous
randomised trial has shown that this intervention was
cost-effective for patients with diabetes with minor to
moderate depression: 9 months after receiving the inter-
vention, depressive symptoms were signiﬁcantly lower,
there was a positive effect on patients’ quality of life, and
patients experienced less anxiety, possessed more self-
efﬁcacy skills, demonstrated better glycaemic control
and showed more participation in comparison to
control patients.17–19 There was an implementation
momentum. The health insurer promised to pay the
costs for the extra care, and the care group gave a com-
mitment to take care of training facilities and integration
of SMS parameters into Electronic Medical Records.
Some adjustments to the nurse-led intervention were
crucial. Where the original intervention had been deliv-
ered at patients’ homes by speciﬁcally trained nurses
from the research team who selected eligible patients by
means of an elaborate diagnostic procedure, in SMS it
was provided by PNs as a structural part of their consul-
tations delivered in the family practice. For the identiﬁ-
cation of eligible patients, a simple detection method
became an inherent part of SMS. The eligibility criteria
changed from having a mild to moderate depression
towards suffering from both emotional distress and inter-
ference in their daily functioning due to the burden of
diabetes. This focus on daily functioning instead of a
diagnosis of depression was supposed to ﬁt the primary
care setting. Patients who were detected by the PN
received the nurse-led minimal psychological interven-
tion or were referred to the GP to see whether more
specialised care would be required, depending on the
severity of the symptoms.
SMS was evaluated by means of a type 2 hybrid
effectiveness-implementation study design, in which the
regional implementation strategies and the effectiveness
of SMS were evaluated simultaneously.20 This paper will
focus on the effectiveness part of the SMS project,
though it is closely connected to the implementation
part. This paper reports the effectiveness of SMS inte-
grated by PNs into routine diabetes consultations regard-
ing patients’ daily functioning, emotional health, quality
of life, autonomy and participation, self-efﬁcacy and self-
management skills, and blood glucose levels.
METHODS
Study design
A two-arm, pragmatic, cluster-randomised controlled
trial was conducted with PNs as the unit of randomisa-
tion and their patients with type 2 diabetes mellitus as
the unit of analysis. Measurements were at baseline, at
4 months and at 12 months. The study was conducted
between November 2011 and February 2013 and was
registered in a Dutch public trial registry [NTR2764].
The study protocol has been published elsewhere.16
Study participants
All the family practices of one regional organisation of
GPs (a so-called ‘care group’) in the South of the
Netherlands were eligible to participate in the study. GPs
were asked to participate in the SMS project. Their PNs
for diabetes care were randomly assigned to an interven-
tion or control arm. PNs in the intervention arm were
trained in SMS, whereas PNs in the control arm pro-
vided usual diabetes care, conforming to the Dutch
guidelines. Owing to the variety of PNs working solo
versus in a team, and in one versus more practices, PNs
were stratiﬁed into working alone in a practice, working
in a team and working in different settings. The ran-
domisation was performed by an independent research
assistant who used a random number seed computer
program to assign PNs to study arms, assuming an alloca-
tion ratio of 1:1. PNs working together in a practice were
clustered for being randomised to the same trial arm to
avoid the risk of contamination if the SMS and usual
care would be delivered in the same family practice.
Regarding the analysis, a team of PNs was seen as one
cluster if patients could receive diabetes care from these
PNs alternately.
In the selection of patients for the effectiveness trial,
the following issues were crucial. First, we wanted to
select patients who would receive the complete interven-
tion including detection and follow-up. Furthermore,
patients from the intervention and control arms should
be selected in a similar way, without interfering in their
routine care. We set up a screening procedure by means
of written questionnaires sent to patients’ home
addresses to identify patients with actual problems of
daily functioning and emotional distress. Patients with a
clinically established diagnosis of type 2 diabetes mellitus
were sent a letter by their GPs to introduce the SMS
project. The enclosed self-administered questionnaire
consisted of the screening instruments that intervention
PNs would also apply for SMS in their routine practice.
It included the ‘Daily Functioning Thermometer’
(DFT), which is a Visual Analogue Scale to measure how
suffering under the burden of diabetes affects patients’
perceived functioning in everyday life. Patients were
asked to indicate a position between 0 (no burden
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at all) and 10 (extreme burden) at a continuous vertical
10 cm line. A score of 4 was chosen to differentiate
between patients who could beneﬁt from support in
their self-management skills (score >4) and patients who
had found a satisfactory way to live with the conse-
quences of their diabetes (score ≤4). The DFT has been
developed for the purpose of this study. It is comparable
to the Distress Thermometer, a validated questionnaire
in the care for patients with cancer,21 and a validated
Visual Analogue Scale regarding the worst (0) and the
best possible life (10) for adolescents with type 1 diabetes
mellitus.22 Next to the DFT, patients were asked to com-
plete the three-item Distress Screener (DS), which is a
quick-scan instrument for emotional distress and an indi-
cator of potential underlying severe mental health pro-
blems.23 Patients with score DFT >4 and DS >3 were
eligible for trial participation. The time interval between
the researcher-driven self-administered screening ques-
tionnaire and the face-to-face nurse-led detection proced-
ure in the consultation room needed to be as short as
possible. However, intervention patients should complete
the baseline measurement before SMS is applied. Owing
to the logistics, patients received the posted screening
questionnaire 4–6 weeks before a planned diabetes con-
sultation. Reminders were sent at least 3 weeks before a
consultation. Patients were asked to return the completed
questionnaire to the research centre and to give
informed consent to be approached if they were found to
be eligible for research follow-up measurements. Within
a week after receiving the screening questionnaire at our
research centre, eligible patients were sent an invitation
letter together with an informed consent form for trial
participation and the baseline measurement. Patients
who gave informed consent knew whether they would
receive an addition to their usual care or not. No details
were given about the content of the intervention.
Intervention: SMS in routine care
During three 8 h training sessions, PNs in the interven-
tion arm were trained to integrate the detection and
follow-up phase of SMS into their daily practice. The
training sessions were followed up by booster sessions to
maintain and improve PNs’ skills in SMS. PNs attended
these booster sessions three or four times during the
year of follow-up.
After the training sessions, PNs started to integrate
SMS into their routine care practice. PNs were blinded
regarding the outcomes of the recruitment procedure
and study participation of their patients. They applied
SMS in all their consultations with patients with diabetes.
Financial reimbursement for the extra time spent on
SMS was added to the bundled payment arrangement
for diabetes care.24
SMS included a detection and follow-up phase. The
ﬂow chart of SMS is presented in ﬁgure 1. The detection
phase of SMS started by exploring whether a patient
experienced problems in daily life. PNs then applied the
DFT by showing patients a vertical line ranging from 0 to
10 with 0 indicating no burden at all and 10 indicating
extreme burden, and asking them to rate the burden of
diabetes in their daily life. PNs also verbally administered
the three questions of the DS.23 Patients with score DS
>3, which indicates high risk for underlying mental
health problems, were asked to complete the
Four-Dimensional Symptom Questionnaire (4DSQ)25
immediately after the consultation. This self-report instru-
ment is widely used in Dutch primary care to distinguish
non-speciﬁc distress from depression, anxiety and soma-
tisation. It differentiates between mild, moderate or
severe symptoms. The completed 4DSQ was returned to
the PN, who computed the sum scores on each domain.
The follow-up phase of SMS was based on the out-
comes of the DFT and 4DSQ. Patients registering a
‘severe’ score on at least one of the four subscales of the
4DSQ were referred to the GP for further diagnostics
and treatment.
Patients who experienced problems of daily functioning
(DFT >4) and emotional health problems (moderate
scores on at least one subscale of the 4DSQ) were offered
consultations for SMS. These extra consultations delivered
by PNs were aimed at supporting patients in their
day-to-day management of diabetes and its emotional and
social consequences. The intervention strategy derived
from the principles of learning theory has been described
elsewhere.26 PNs supported patients in the processes of
deﬁning problems and ﬁnding solutions themselves, by
applying problem-solving and reattribution techniques.
Problem-solving consists of seven stages that efﬁciently
address problems and their possible solutions.27 The reat-
tribution technique was applied to challenge patients to
link feelings and cognition to consequent behaviour.
Patients could use information from a diary in which they
recorded symptoms, thoughts, worries, feelings, and
behaviour. Both problem solving and reattribution techni-
ques were intended to result in action plans indicating
how patients would achieve their personal goals.28
Measurements effectiveness trial
We used postal questionnaires for patient measurements.
Patient characteristics regarding their age, sex, year of
diagnosis, treatment of diabetes (insulin therapy or
tablets), marital status, work status and educational level
were assessed at baseline.
The glycaemic control of patients was measured
during diabetes consultations. These measurements
were extracted from the electronic patient databases.
In the year following the training, PNs in the interven-
tion arm recorded process measures and outcomes of
SMS on a speciﬁc registration form. These data were
used to evaluate whether patients were exposed to SMS.
Outcomes
The effect of SMS on patients’ daily functioning was mea-
sured by means of the DFT. The DFT was dichotomised
to compare the number of patients who were improved
in their daily functioning and had apparently found a
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satisfactory way to live with the consequences of their dia-
betes (DFT ≤4) with patients who still perceived a
burden of diabetes on their daily functioning (DFT >4).
The secondary outcome measure ‘diabetes-related
emotional distress’ was measured by the 20-item
Problem Areas in Diabetes questionnaire (PAID).29–31
Scores were transformed to a 0–100 scale, with 0 being
the most favourable outcome. Missing items were
imputed using patients’ individual mean score if at least
50% of items were available.
Participation and autonomy were measured by means
of the Impact on Participation and Autonomy (IPA)
questionnaire.32 The response options of the 32 items
ranged from 0 to 4 with higher scores representing
poorer participation and autonomy. Five subscale scores
were computed: autonomy indoors (range 0–28), family
role (range 0–28), autonomy outdoors (range 0–20),
social relationships (range 0–28) and work and educa-
tion (range 0–24). In accordance with the manual,
missing items were imputed using the individual mean
scores of items that were not missing in patients for
whom at least 75% of items were available.33
Patients’ self-management knowledge and behaviours
regarding their diabetes were measured using the Dutch
version of the Partners in Health scale (PIH-NL).34 The
12 items covered four domains of patients’ competency
in relation to their self-management (knowledge, coping,
management of condition and adherence to treatment).
We used the total sum score.
The 12-item Short-Form Health Survey (SF-12) mea-
sured the quality of life.35 A physical component summary
and a mental component summary were computed by
using item weights and regression constants for the Dutch
population derived from the oblique rotation method.36 37
The norm-based summary scores have a mean of 50 and
an SD of 10 in the Dutch population.37 Higher scores
reﬂect better outcomes on the quality of life.
The General Self-Efﬁcacy Scale (GSES-12) assessed
patients’ belief in their ability to organise and engage in
certain behaviours.38 39 A higher sum score (range
12–60) reﬂects higher levels of self-efﬁcacy. Missing
items were imputed using patients’ individual mean
score if at least 50% of items were available.
The glycated haemoglobin in mmol/mol was measured
during consultations. For the baseline measure, we used
data from the ﬁrst consultation after the patient’s base-
line measurement (with a maximum interval of
3 months). The consultation following this ﬁrst consult-
ation was used as the 4-month follow-up measurement.
The last measurement was the assessment approximately
1 year after the patient’s baseline measurement (at least
more than 6 months after the ﬁrst consultation).
Figure 1 Self-Management
Support (SMS) as implemented
in routine care. DFT, Daily
Functioning Thermometer; DS,
Distress Screener; 4DSQ,
Four-Dimensional Symptom
Questionnaire; GP, general
practitioner.
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Statistical analysis
The power calculation was based on the dichotomous
DFT.16 On the basis of a group size of 46 PNs, we deter-
mined in advance that a sample size of 232 patients
(at least 5 patients per PN) would have 90% power and an
α of 0.05 to detect an improvement in perceived daily
functioning (deﬁned as DFT ≤4) at 12 months measure-
ment occurring in 20% of patients in the intervention arm
versus 5% of those in the control arm. In this power calcu-
lation for cluster-randomised trials, an intraclass correl-
ation coefﬁcient of 0.04 was used. Assuming that not all
positively screened patients would give informed consent
for trial participation, and a 30% loss to follow-up, we
planned to invite 10 eligible patients for each PN.
Baseline variables were compared by means of
independent-samples t tests and χ2 tests to detect statis-
tically signiﬁcant differences between both groups at
baseline. For the effect evaluation, linear and logistic
multilevel models were used with an unstructured covari-
ance structure for repeated measures, and patients and
PNs as random factors. These models account for the
correlation between the repeated measurements for
each patient and also for the hierarchical structure of
the data, with measurements (level-1) clustered within
patients (level-2) who in turn were clustered within PNs
(level-3). Type of practice, that is, the stratiﬁcation vari-
able, time of measurement (categories: 0, 4 and 12) and
the interaction between group and time of measurement
were included in the models as ﬁxed effects. Analyses
were performed on an intention-to-treat basis.
To ensure that all participants of the intervention and
control arms started with a score DFT >4, indicating a
perceived burden of diabetes, we used the dichotomised
research-led screening outcomes at baseline.
Consequently, the model only included 4-month and
12-month follow-ups as the baseline value was the same
for all participants.
A two-sided p value <0.05 was considered statistically
signiﬁcant. Statistical analyses were conducted using the
software packages IBM SPSS Statistics V.21.0 for Windows
and SAS V.9.3.
RESULTS
Participants
From the 77 family practices that were approached
between April and June 2011, 40 agreed to participate.
Their PNs (n=41) were by randomisation assigned to the
intervention arm (20 PNs) and the control arm (21 PNs).
After randomisation, but before patient recruitment, one
family practice in the intervention arm withdrew from
study participation due to the heavy workload of the PN.
This left 19 PNs who received training in SMS and inte-
grated it into their daily practice, and 21 PNs in the
control arm who provided usual care.12 As some PNs
worked together in a team, 15 units of analysis were left
in the intervention arm and 19 units of analysis in the
control arm.
A total number of 3822 patients with diabetes were
sent a screening questionnaire in the period from
October 2011 to March 2012. The response rate was
50% in the intervention arm and 44% in the control
arm. As screening questionnaires were sent by GPs, we
could not compare responders with non-responders with
regard to demographic characteristics.
From all 1805 patients who participated in the screen-
ing, 357 (20%) met the detection criteria and were
invited to take part in the trial. A total of 264 patients
(74%) gave informed consent to participate in the trial.
Their research-led screening outcomes were not signiﬁ-
cantly different from outcomes from eligible patients
who refused trial participation.
From the 117 intervention patients and 147 control
patients who participated in the trial, 80% completed all
of the follow-up measurements. In 10% of the sample,
one follow-up measurement was missing. Three patients
did not complete the baseline measurement and gave
informed consent at the 4-month follow-up measure-
ment. Another 23 patients completed only the baseline
measurement. We found no baseline variables that were
signiﬁcantly related to incompleteness of measurements.
Figure 2 illustrates the ﬂow of recruitment and random-
isation of PNs, screening of patients and measurements
of trial participants.
Baseline characteristics
Table 1 illustrates the baseline characteristics of partici-
pants in the SMS trial.
The sample comprised 46% female patients with the
majority having a lower level of education. The average
age of the participants was 65. Of all 121 participants
younger than 65 years, 41% had paid employment. The
proportion of patients with a paid job was signiﬁcantly
higher in the intervention arm than in the control arm.
On average, patients had been diagnosed with diabetes
for 8–9 years. The majority were being treated with oral
hypoglycaemic medication. The number of patients
being treated with insulin was signiﬁcantly higher in the
intervention group (33%) compared to patients in the
control group (16%). At the time of baseline measure-
ment, 84% were not receiving psychosocial care from a
health professional.
Patients of both groups were comparable for the
primary and secondary outcomes at the baseline meas-
urement except for the sum score on the PIH scale.
This reﬂected better self-management skills of interven-
tion patients regarding knowledge, symptom manage-
ment and adherence to treatment. Both groups were
comparable regarding the subdomain ‘coping’ that
included three items about dealing with the effects of
diabetes on daily life.
Study participants’ exposure to SMS
An unexpected outcome was the very low exposure to SMS
of the study participants in the intervention arm. It is pre-
sented in table 2. PNs did not register any data about SMS
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for 17 participants (15%) in the patient ﬁle during the
year of follow-up. For the other 100 participants, between
1 and 5 diabetes consultations were registered with data
on the DFT and DS. The combination of DFT >4 and DS
>3 was found in only 16 participants (14%).
A total of 46 study participants scored neither DFT >4
nor DS >3 during consultations. The low detection rates
also implied low exposure to the follow-up phase of SMS.
From 30 participants who scored DS >3 and were
therefore eligible for further diagnostics, 10 patients did
not receive the 4DSQ because (1) they were already
undergoing psychological treatment, or (2) they were
not interested, or (3) a speciﬁc stressor was clearly
causing the distress. Extra consultations for SMS were
provided for 11 participants, of whom there were only
two patients with a nurse-led detection score of DFT >4
and DS >3. From the other 14 participants with positive
scores for DFT and DS, six patients were referred to the
GP and one patient to a mental nurse because severe
mental health problems were recorded using the 4DSQ.
Five participants with score DFT >4 and DS >3 did not
want to receive follow-up care, and two participants were
already receiving psychological treatment.
Primary outcome
As illustrated in table 3, the number of patients who
improved in their daily functioning (score DFT ≤4) was
lower in the intervention group than in the control
Figure 2 Flow of participants
through the Self-Management
Support (SMS) trial. DFT, Daily
Functioning Thermometer; PNs,
practice nurses.
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group at 4-month follow-up, but this was not a statistic-
ally signiﬁcant difference (24% vs 32%; OR: 0.505 (95%
CI 0.213 to 1.201)). At the 12-month follow-up, more
patients in the intervention group improved in their
daily functioning compared to patients in the control
group. However, this was not statistically signiﬁcant
either (33% vs 26%, OR 1.754 (95% CI 0.742 to 4.148)).
Secondary outcomes
For the secondary outcome measures, the intervention
group perceived signiﬁcantly more participation than
the control group regarding autonomy indoors and
family role (p<0.05) after 4 months. The same applied,
with nearly statistically signiﬁcant differences, for auton-
omy outdoors (p=0.06) and social relationships
(p=0.05). However, these effects disappeared at
12-month follow-up. As illustrated in table 4, we found
no other statistically signiﬁcant differences for the sec-
ondary outcome measures at 4 and 12 months.
DISCUSSION
This study, with a low exposure of study participants to
the complete intervention, could not demonstrate any
effect of SMS on emotional, social or biomedical para-
meters, except for autonomy and participation with
regard to activities indoors and the family role after
4 months. This effect in favour of the patients in the
intervention arm had disappeared after 12 months.
The critical issue of the implementation of SMS was
the addition of a detection procedure as an inherent
and integrated part of SMS. PNs were trained to identify
eligible patients for the follow-up phase of SMS by apply-
ing screening questions during diabetes consultations.
Table 1 Baseline characteristics of study participants in intervention and control arms
Characteristics Categories
Intervention arm
(n=117)
Control arm
(n=147)
Gender Female 55 (47) 67 (46)
Age Mean (SD) age (years) 64 (10) 65 (9)
Diagnosis of diabetes Mean (SD) duration (years) 9 (8) 8 (6)
Ethnicity Non-western 2 (1.7) 0 (0)
Education* Low 80 (72) 103 (74)
Work status of patients
<65 years†
Paid job 28 of 55 (51) 21 of 66 (32)
Marital status Married 76 (66) 92 (64)
Single 5 (4) 12 (8)
Divorced 16 (14) 21 (14)
Widowed 19 (16) 19 (13)
Treatment† Diet only 8 (7) 12 (8)
Tablets 69 (61) 108 (76)
Insulin 10 (9) 4 (3)
Insulin and tablets 27 (24) 19 (13)
Psychological care No psychological care 96 (83) 123 (86)
In primary care setting 17 (15) 16 (11)
In secondary care setting 3 (3) 4 (3)
Health outcomes Scale (range) Mean (SD) Mean (SD)
p Value
t Test
Daily functioning DFT (0–10) at screening 6.8 (1.3) 6.6 (1.3) 0.205
Blood glucose HbA1c in mmol/mol 53.0 (11.2) 51.8 (10.2) 0.429
Diabetes-related distress PAID (0–100) 29.9 (16.9) 28.9 (19.4) 0.684
Participation and autonomy IPA autonomy indoors (0–28) 6.9 (4.8) 6.7 (4.5) 0.734
IPA family role (0–28) 12.7 (5.5) 12.8 (5.7) 0.921
IPA autonomy outdoors (0–20) 8.6 (4.2) 8.4 (4.2) 0.681
IPA social relationships (0–28) 9.6 (4.6) 9.4 (4.3) 0.631
IPA work and education (0–24) 11.1 (3.5) 9.4 (3.2) 0.116
Self-management PIH (0–96) 78.0 (8.9) 73.2 (14.5) 0.002†
Quality of life SF-12 Physical component 34.8 (9.6) 35.0 (9.8) 0.849
SF-12 Mental component 34.1 (11.3) 35.2 (11.2) 0.456
Self-efficacy GSES (12–60) 38.6 (7.5) 39.2 (7.0) 0.481
Values are numbers (percentages) unless stated otherwise.
*Low refers to primary school, lower vocational training or lower general education.
†Significant differences: p<0.05.
HbA1c, glycated haemoglobin. DFT, Daily Functioning Thermometer; PAID, Problem Areas in Diabetes; IPA, Impact on Participation and
Autonomy; lower mean scores reflect better outcomes. PIH, Partners in Health Scale; SF-12, Short Form Health Questionnaire Physical and
Mental component, mean score Dutch population is 50; GSES, General Self-efficacy scale; higher scores refer to better outcomes.
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The DFT and DS were considered to be simple, patient-
centred indicators of patients’ daily functioning and
their emotional distress. The 4DSQ would enable the
PNs and GPs to get more insight into the presence and
severity of the emotional problems. For the effectiveness
trial, a self-administered postal screening procedure was
inserted into the study design to select patients from
both the intervention and control arms similarly. To
perform a pragmatic trial, we minimised the interfer-
ence of the researchers in clinical practice as much as
possible. The outcomes of DFT and DS on the research-
driven screening were consistent with our assumptions
based on the literature that approximately 20% of the
diabetic population would be eligible for the follow-up
phase of SMS. However, these efforts to select patients
with emotional problems, aimed at increasing the con-
trast between patients in the intervention and control
arms, appeared to be useless as the added detection
method in routine practice did not function as
expected. This was not a problem of PNs’ adherence to
the SMS protocol, as the screening tools were integrated
into diabetes consultations of more than 85% of the
study participants. The problem was that the majority of
study participants who scored above the cut-off values on
the postal questionnaires did not meet the required
detection criteria when screened face to face by the PNs.
These patients were therefore not exposed to the follow-
up phase of SMS. We have no reason to assume that
non-respondents on the research-driven screening were
those most in distress, who would have been the easiest
to be detected by the PNs, as low detection rates were
reported for the whole diabetic population in the inter-
vention practices.
Differences between the self-administered screening
outcomes and the nurse-led detection could be
explained by the ﬂuctuation in distress symptoms and
the phenomenon of regression towards the mean. This
may have resulted in study participants scoring less
extreme values at nurse-led detection compared to
values at research-driven screening. Furthermore, tests
may function differently across settings and administra-
tion methods.40 Owing to patients’ difﬁculty in expres-
sing emotional problems during consultations and lack
of recognition by health professionals of emotional pro-
blems experienced by patients with chronic physical
illness, the chance of positive screening outcomes
seems to have been higher in anonymous research-
driven screening than in clinical practice.41 42
Nonetheless, we did not expect such a large discrep-
ancy between research-driven screening and nurse-led
detection.
For 17 of the 117 study participants, no data on SMS
activities were registered, suggesting that these patients
were exposed neither to the detection phase nor the
follow-up phase of SMS. The reasons for this phenom-
enon could be twofold. First, PNs had to integrate SMS
into all consultations while the effects were assessed in
only a few patients per PN. PNs did not know which
Table 2 Exposure to SMS of study participants in the intervention arm (n=117)
N
Outcome
detection
4DSQ completed of those
who received the 4DSQ*
4DSQ
Outcome
Self-Management
Support Referral
46 DFT ≤4 and DS ≤3 – – 2 –
1 of 2 1 mild – –
24 Only DFT >4 – – 1
3 of 3 2 mild – –
1 moderate 1
14 Only DS >3 5 of 8 2 moderate 2
3 severe 3
16 DFT >4 and DS >3 12 of 12 4 moderate 2 1
8 severe – 6
17 No registration – – – –
Total 117 21 of 25 11 7
*PNs were instructed to give the 4DSQ to patients with score DS >3.
HbA1c, glycated haemoglobin. DFT, Daily Functioning Thermometer; PAID, Problem Areas in Diabetes; IPA, Impact on Participation and
Autonomy; lower mean scores reflect better outcomes. PIH, Partners in Health Scale; SF-12, Short Form Health Questionnaire Physical and
Mental component, mean score Dutch population is 50; GSES, General Self-efficacy scale; higher scores refer to better outcomes.
Table 3 Multilevel analyses for differences between intervention and control arms regarding improvement on patients’ daily
functioning reflected by the dichotomous primary outcome (DFT ≤4) at 4-month follow-up and at 12-month follow-up
Intervention Control OR 95% CI p Value
DFT ≤4 Yes/N (%) Yes/N (%)
4 months 24/102 (23.5) 40/126 (31.7) 0.505 0.213 to 1.201 0.12
12 months 32/96 (33.3) 32/121 (26.4) 1.754 0.742 to 4.148 0.20
DFT, Daily Functioning Thermometer.
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patients participated in the trial. As PNs’ integration of
SMS into consultations could have ﬂuctuated during
follow-up, they may have missed study participants.
Second, registration bias may have occurred. PNs needed
to open an extra data ﬁle to record the process and out-
comes of SMS. This step might have created a barrier to
their compliance. This underlines the need for a thor-
ough process evaluation of how and under what condi-
tions the intervention procedure was carried out. In this
regard, the simultaneous evaluation of the implementa-
tion process will reveal important issues. The outcomes of
this process evaluation will be presented elsewhere.
In the planning of the study, we considered avoiding
research-driven screening by inserting the nurse-led
detection phase of SMS into both study arms. However,
monitoring and discussing psychological well-being as
part of routine care may already have positive effects on
patients’ moods.43 Moreover, from an ethical perspec-
tive, patients in the control arm who would be detected
positively for mental health problems would need to be
referred for further diagnosis or psychosocial treatment,
thus changing the usual care. Using research-led screen-
ing was therefore assumed to be the most adequate solu-
tion for the selection of participants for the effectiveness
part of the study. In retrospect, a pilot study should have
been part of our implementation project. It was not
planned for several reasons. There was an implementa-
tion moment. Besides, we could use the experiences
from the former study, in which the treatment phase was
evaluated. PNs would receive comprehensive training,
and they would ask common questions about psycho-
social functioning. Furthermore, the outcomes of the
screening did not give rise to questions about the instru-
ments: as expected, 20% of the respondents met the
detection criteria.
Although collaboration with regional stakeholders
resulted in organisational and ﬁnancial beneﬁts for
family practices willing to participate, this incentive did
not appear to be a decisive factor in the process of con-
sidering whether or not to participate. For robust multi-
level modelling, it is necessary that sufﬁcient clusters are
recruited and sufﬁcient patients are available per
Table 4 Multilevel analyses for differences between intervention arm and control arm for secondary outcome measures at
4-month and 12-month follow-ups
Outcome measure
(range) Scale (range)
Mean (SD) Adjusted treatment effect
Intervention
arm
Control
arm
Difference
in mean 95% CI p Value
At 4-month follow-up
Blood glucose HbA1c in mmol/mol 54.7 (11.0) 52.1 (9.6) −0.03 −1.97 1.91 0.98
Diabetes-related distress PAID (0–100) 26.1 (16.5) 27.0 (19.7) −2.22 −5.46 1.01 0.18
Participation and
autonomy
IPA indoors (0–28) 5.9 (4.4) 7.0 (5.1) −1.27 −2.25 −0.30 0.01*
IPA family role (0–28) 11.4 (5.3) 12.8 (6.0) −1.25 −2.33 −0.17 0.02*
IPA outdoors (0–20) 7.5 (4.0) 8.1 (4.3) −0.69 −1.43 0.03 0.06
IPA social relationships
(0–28)
8.4 (4.3) 9.3 (4.7) −0.83 −1.64 −0.01 0.05
IPA work and education
(0–24)
10.3 (5.7) 9.4 (5.7) +0.01 −2.14 2.17 0.99
Self-management PIH (0–96) 79.9 (7.9) 76.3 (12.3) +0.01 −2.19 2.21 0.99
Quality of life SF-12 Physical component 35.4 (10.0) 35.7 (10.4) +0.17 −1.62 1.96 0.85
Quality of life SF-12 Mental component 37.1 (11.4) 38.5 (11.7) −0.99 −3.54 1.55 0.44
Self-efficacy GSES (12–60) 39.5 (7.1) 39.8 (7.4) +0.15 −1.05 1.36 0.81
At 12-month follow-up
Blood glucose HbA1c in mmol/mol 51.5 (10.8) 50.4 (9.6) −0.80 −2.75 1.15 0.42
Diabetes-related distress PAID (0–100) 27.8 (17.7) 24.2 (16.9) +0.65 −2.64 3.93 0.70
Participation and
autonomy
IPA indoors (0–28) 6.6 (4.6) 7.4 (5.2) −0.63 −1.63 0.36 0.21
IPA family role (0–28) 12.0 (6.2) 12.5 (5.9) −0.13 −1.24 0.97 0.81
IPA outdoors (0–20) 8.5 (4.1) 7.9 (4.0) +0.56 −0.19 1.30 0.14
IPA social relationships
(0–28)
9.1 (4.4) 8.9 (4.0) −0.01 −0.84 0.81 0.98
IPA work and education
(0–24)
11.4 (5.2) 11.5 (4.5) +0.02 −2.09 2.13 0.98
Self-management PIH (0–96) 78.6 (8.6) 77.9 (10.7) −2.25 −4.49 −0.01 0.05
Quality of life SF-12 Physical component 36.3 (10.5) 34.9 (10.6) +0.33 −1.48 2.14 0.72
Quality of life SF-12 Mental component 37.5 (11.9) 37.3 (10.8) +0.43 −2.15 3.01 0.74
Self-efficacy GSES (12–60) 38.6 (7.6) 40.3 (6.9) −0.69 −1.92 0.54 0.27
*Statistically significant difference (p<0.05).
DFT, Daily Functioning Thermometer; GSES, General Self-efficacy scale; higher scores refer to better outcomes; HbA1c, glycated
haemoglobin; PAID, Problem Areas in Diabetes; IPA, Impact on Participation and Autonomy; lower mean scores reflect better outcomes;
PIH, Partners in Health Scale. SF-12=Short Form Health Questionnaire Physical and Mental component, mean score Dutch population is 50.
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cluster.44 Our intention was to include 46 PNs, but
only 40 PNs participated. Furthermore, the ﬁnal total
number of clusters for analysis was actually only 33 as
some patients were seen alternately by PNs working in a
team. Owing to the regional approach of the SMS
project, we were conﬁned to the family practices within
the region under study. The number of patients within
clusters ranged from 1 to 19. The loss to follow-up of
patients was less than expected, which led to an accept-
able total number of study participants. However, the
availability of clusters as well as the balance between clus-
ters needs attention when designing a cluster-
randomised trial that will be performed in an implemen-
tation setting.
In implementation studies, formative evaluation
methods can be used to adapt or optimise the imple-
mentation or intervention itself during the study.20
Owing to the trial protocol and time and research
funding limitations, we did not further optimise the
intervention or implementation strategies other than to
inform PNs after 3-month follow-up to use the criteria
DFT >4 and DS >3 less rigidly. The planning of a more
ﬂexible design of the effectiveness trial within the hybrid
design would have been helpful in overcoming imple-
mentation problems. This calls for inclusion of speciﬁc
evaluation moments to decide about the need for adjust-
ments in the intervention itself, in implementation activ-
ities or with regard to follow-up measurements.
In conclusion, the adjusted nurse-led intervention in
its present form was not effective. There was a dilution
of the contrast between intervention and control
patients. This is because outcomes of the detection
method, added for implementation purposes, were
neither optimal nor congruent with outcomes of the
screening method added for research purposes. We do
not know whether SMS would be effective if PNs used
other methods to identify patients in need for support
in their emotional and role management skills.
Blending effectiveness and implementation studies may
have the potential to facilitate a rapid adoption of
evidence-based care innovations in routine practice and
to provide useful information for decision-makers about
effects and implementation issues,20 but researchers who
are planning a hybrid effectiveness-implementation
study need to be aware of the necessity to build in
adequate follow-up moments and to take action either
to remove identiﬁed barriers or to adapt the interven-
tion to an acceptable level.
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